CGT
GILD icon

Capital Guardian Trust’s Gilead Sciences GILD Stock Holding History

Capital Guardian Trust’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		$13.3M Sell
196,965
-27,505
-12% -$1.81M 0.18% 128
2019
Q1 		$14.5M Sell
224,470
-58,597
-21% -$3.89M 0.19% 118
2018
Q4 		$17.7M Sell
283,067
-18,885
-6% -$1.32M 0.28% 106
2018
Q3 		$23.3M Sell
301,952
-6,708
-2% -$507K 0.31% 103
2018
Q2 		$21.9M Sell
308,660
-9,018
-3% -$637K 0.31% 102
2018
Q1 		$23.9M Buy
317,678
+44,167
+16% +$3.51M 0.34% 105
2017
Q4 		$19.6M Buy
273,511
+199,009
+267% +$15.1M 0.28% 113
2017
Q3 		$6.04M Buy
74,502
+32,752
+78% +$2.5M 0.11% 134
2017
Q2 		$2.96M Sell
41,750
-591,049
-93% -$39.3M 0.05% 145
2017
Q1 		$43M Sell
632,799
-206,099
-25% -$14.5M 0.32% 106
2016
Q4 		$60.1M Sell
838,898
-97,999
-10% -$7.28M 0.47% 79
2016
Q3 		$74.1M Sell
936,897
-121,073
-11% -$9.84M 0.56% 72
2016
Q2 		$88.3M Sell
1,057,970
-84,517
-7% -$7.5M 0.68% 54
2016
Q1 		$105M Sell
1,142,487
-307,623
-21% -$27.7M 0.81% 44
2015
Q4 		$147M Sell
1,450,110
-85,474
-6% -$8.89M 1.14% 24
2015
Q3 		$151M Sell
1,535,584
-352,040
-19% -$39.1M 1.22% 23
2015
Q2 		$221M Sell
1,887,624
-27,456
-1% -$3M 1.59% 6
2015
Q1 		$188M Sell
1,915,080
-1,841,204
-49% -$187M 1.39% 14
2014
Q4 		$354M Sell
3,756,284
-1,621,639
-30% -$168M 2.45% 1
2014
Q3 		$572M Sell
5,377,923
-947,586
-15% -$92.8M 4.08% 1
2014
Q2 		$524M Sell
6,325,509
-1,056,603
-14% -$82.2M 3.57% 1
2014
Q1 		$523M Sell
7,382,112
-1,987,064
-21% -$156M 3.54% 1
2013
Q4 		$704M Sell
9,369,176
-865,114
-8% -$60.2M 4.64% 1
2013
Q3 		$643M Sell
10,234,290
-2,049,307
-17% -$122M 4.45% 1
2013
Q2 		$629M Buy
+12,283,597
New +$640M 4.37% 1

Other funds holding GILD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
AAMU
Amundi Asset Management US Boston, Massachusetts $131B AUM 73.57% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Capital Guardian Trust's GILD Position: Q2 2019 in Review

Capital Guardian Trust reduced its Gilead Sciences (GILD) stake by 12% in Q2 2019, selling an estimated $1.81M and leaving 196,965 shares worth $13.3M. The position accounts for 0.18% of the portfolio, ranked #128.

Capital Guardian Trust first reported a position in GILD in Q2 2013 and has held it in 25 quarters since. The position peaked at $704M in Q4 2013. 1,483 funds tracked by Wall St. Rank hold GILD as of Q2 2019.

  • Capital Guardian Trust held 196,965 shares of Gilead Sciences worth $13.3M as of Q2 2019.
  • Capital Guardian Trust sold 27,505 Gilead Sciences shares in Q2 2019, an estimated $1.81M.
  • Gilead Sciences made up 0.18% of Capital Guardian Trust's portfolio in Q2 2019, its #128 holding.
  • Capital Guardian Trust first reported a position in Gilead Sciences in Q2 2013 and has held it in 25 quarters since.
  • Capital Guardian Trust's Gilead Sciences position peaked at $704M in Q4 2013.
  • 1,483 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2019.

Based on Capital Guardian Trust's 13F filing for Q2 2019, filed 14 Aug 2019.